Sunny Optical Technology SG&A Expenses 2019-2024 | SNPTF
Sunny Optical Technology annual/quarterly sg&a expenses history and growth rate from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Sunny Optical Technology sg&a expenses for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
- Sunny Optical Technology sg&a expenses for the twelve months ending June 30, 2024 were $0M, a NAN% increase year-over-year.
- Sunny Optical Technology annual sg&a expenses for 2023 were $0.201B, a 5.75% increase from 2022.
- Sunny Optical Technology annual sg&a expenses for 2022 were $0.19B, a 19.15% increase from 2021.
- Sunny Optical Technology annual sg&a expenses for 2021 were $0.16B, a 6.86% increase from 2020.
| Sunny Optical Technology Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $201 |
| 2022 | $190 |
| 2021 | $160 |
| 2020 | $150 |
| 2019 | $134 |
| 2018 | $97 |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| Sunny Optical Technology Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $11.331B | $4.483B |
| Sunny Optical Technology Group Co., Limited is engaged in the design, research and development, manufacture and sales of optical and optical-related products. Optical components product includes glass spherical and aspherical lenses, plane products, handset lens sets, vehicle lens sets and other various lens sets. Optoelectronic products includes handset camera modules, three-dimensional optoelectronic products, security cameras and other optoelectronic modules and optical instruments includes microscopes, optical measuring instruments and various high-end optical analytical instrument. Sunny Optical Technology Group Co., Limited is based in Yuyao, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.174B | 28.29 |
| Boston Scientific (BSX) | United States | $155.945B | 42.10 |
| Stryker (SYK) | United States | $148.251B | 31.87 |
| EssilorLuxottica (ESLOY) | France | $140.098B | 0.00 |
| Medtronic (MDT) | Ireland | $111.559B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.232B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.180B | 29.35 |
| GE HealthCare Technologies (GEHC) | United States | $42.309B | 20.61 |
| Agilent Technologies (A) | United States | $39.127B | 25.93 |
| ResMed (RMD) | United States | $34.442B | 26.53 |
| Terumo (TRUMY) | Japan | $26.591B | 37.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.545B | 16.81 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.572B | 12.92 |
| Insulet (PODD) | United States | $19.899B | 79.24 |
| Baxter (BAX) | United States | $15.736B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.201B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.927B | 37.20 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.944B | 27.52 |
| Lantheus Holdings (LNTH) | United States | $5.659B | 13.15 |
| Prestige Consumer Healthcare (PBH) | United States | $4.205B | 20.07 |
| ICU Medical (ICUI) | United States | $4.019B | 38.26 |
| Envista Holdings (NVST) | United States | $3.747B | 29.81 |
| Perrigo (PRGO) | Ireland | $3.383B | 9.96 |
| Haemonetics (HAE) | United States | $3.198B | 15.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.913B | 19.63 |
| QuidelOrtho (QDEL) | United States | $2.817B | 23.67 |
| LeMaitre Vascular (LMAT) | United States | $2.319B | 56.37 |
| Neogen (NEOG) | United States | $2.232B | 25.73 |
| AtriCure (ATRC) | United States | $1.907B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.89 |
| InMode (INMD) | Israel | $1.349B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.296B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.211B | 8.65 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.030B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.979B | 15.01 |
| Evolus (EOLS) | United States | $0.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.918B | 0.00 |
| CeriBell (CBLL) | United States | $0.794B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.686B | 0.00 |
| Valneva SE (VALN) | France | $0.613B | 0.00 |
| Omeros (OMER) | United States | $0.536B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.527B | 4.12 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| SNDL (SNDL) | Canada | $0.465B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 31.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.341B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.318B | 57.90 |
| Viemed Healthcare (VMD) | United States | $0.315B | 30.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.301B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.294B | 19.70 |
| Biote (BTMD) | United States | $0.266B | 5.83 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.239B | 50.13 |
| Sanuwave Health (SNWV) | United States | $0.236B | 3.31 |
| Brainsway (BWAY) | Israel | $0.213B | 113.20 |
| High Tide (HITI) | Canada | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.40 |
| MacroGenics (MGNX) | United States | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.167B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.65 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 13.08 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Exagen (XGN) | United States | $0.068B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.052B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.049B | 14.17 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| INLIF (INLF) | $0.046B | 0.00 | |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |